General Information of the Compound
Compound ID |
CP0392928
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-[3-[(2S,5S,11R,14R)-14-(3-aminopropyl)-11-[(4-hydroxyphenyl)methyl]-13-methyl-5-(naphthalen-2-ylmethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentazacyclopentadec-2-yl]propyl]guanidine
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C36H47N9O6
|
||||||||||||||||||
Molecular Weight |
701.829
|
||||||||||||||||||
Canonical SMILES |
CN1[C@H](CCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc2ccc3ccccc3c2)C(=O)NCC(=O)N[C@H](Cc2ccc(O)cc2)C1=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C36H47N9O6/c1-45-30(9-4-16-37)34(50)43-27(8-5-17-40-36(38)39)33(49)44-28(20-23-10-13-24-6-2-3-7-25(24)18-23)32(48)41-21-31(47)42-29(35(45)51)19-22-11-14-26(46)15-12-22/h2-3,6-7,10-15,18,27-30,46H,4-5,8-9,16-17,19-21,37H2,1H3,(H,41,48)(H,42,47)(H,43,50)(H,44,49)(H4,38,39,40)/t27-,28-,29+,30+/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
RYBIIIZNUPUDLJ-VZNYXHRGSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound